Results 161 to 170 of about 1,268 (176)

Reassessing the steroid-sparing potential of efgartigimod in gMG

Journal of the Neurological Sciences
Jie, Yuan, Xuemei, Li, Yuan, Liu
openaire   +2 more sources

Efgartigimod-alfa/mycophenolate/pyridostigmine

Reactions Weekly
openaire   +1 more source

Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial

Journal of Thoracic Oncology
Zhaozhao Cheng, Xiangnan Xu, Xifei Jiang   +2 more
exaly  

Efgartigimod as a fast-acting add-on therapy in manifest and impending myasthenic crisis: A single-center case series

Journal of Neuroimmunology
Lin Gao, Hong-Dong Zhao
exaly  

Successful Treatment of Evans Syndrome With efgartigimod: A Case Report

American Journal of Therapeutics
Yasuyuki, Inoue, Shigeki, Kosugi
openaire   +2 more sources

Efgartigimod-alfa/immune-globulin

Reactions Weekly
openaire   +1 more source

Efgartigimod is a new option for the treatment of thymoma associated myasthenia gravis: A case report

International Journal of Surgery Case Reports
Lirong Jin, Jianyong Ding
exaly  

Efgartigimod bei CIDP effektiv

Fortschritte der Neurologie · Psychiatrie
openaire   +1 more source

Azathioprine/efgartigimod-alfa/rituximab

Reactions Weekly
openaire   +1 more source

Efgartigimod alfa (Vyvgart) for myasthenia gravis.

The Medical letter on drugs and therapeutics, 2022
openaire   +1 more source